Institutions / DIADEMA PARTNERS LP / Holdings
Back to DIADEMA PARTNERS LP

Diadema Partners LP

All holdings · as of Dec 31, 2025

73 positions

CompanyClassValue ↓Shares% of portfolio
Terns Pharmaceuticals, Inc.—$13.97M345,8808.3%
JOHNSON & JOHNSON—$13.75M66,4448.2%
Viking Therapeutics Inc—$11.85M336,8497.1%
ABIVAX SA—$10.20M75,6446.1%
BioMarin Pharmaceutical Inc—$8.70M146,3615.2%
REGENERON PHARMACEUTICALS, INC.—$7.95M10,3004.7%
BridgeBio Pharma, Inc.—$5.35M70,0003.2%
United Therapeutics Corp—$4.87M10,0002.9%
Cogent Biosciences, Inc.—$4.68M131,8522.8%
CAPRICOR THERAPEUTICS, INC.—$4.56M158,0752.7%
VERTEX PHARMACEUTICALS INC / MA—$4.53M10,0002.7%
ANI PHARMACEUTICALS INC—$4.21M53,3542.5%
TG Therapeutics Inc—$3.68M123,2832.2%
BioAge Labs, Inc.BIOACommon Stock$3.59M271,1642.1%
CORCEPT THERAPEUTICS INC—$3.39M97,4452.0%
Tenax Therapeutics, Inc.—$2.96M243,1701.8%
Revolution Medicines, Inc.—$2.95M37,0201.8%
IMMUNOCORE HOLDINGS PLC-ADRIMCRADR$2.44M70,3001.5%
IRONWOOD PHARMACEUTICALS INC—$2.30M683,6111.4%
CENTESSA PHARMACEUTICALS PLC—$2.25M90,0001.3%
Replimune Group, Inc.—$2.25M230,9971.3%
ELI LILLY & Co—$2.15M2,0001.3%
Alnylam Pharmaceuticals Inc—$2.12M5,3411.3%
Lipocine Inc.LPCNCommon Stock$2.10M260,9391.2%
PROTAGONIST THERAPEUTICS INC—$1.98M22,7001.2%
Relmada Therapeutics, Inc.—$1.88M389,3951.1%
Ventyx Biosciences, Inc.—$1.81M200,0001.1%
Annexon, Inc.—$1.76M350,0001.0%
MANNKIND CORP—$1.71M302,0001.0%
INVENTIVA SA—$1.55M334,2510.9%
BIOCRYST PHARMACEUTICALS INC—$1.49M190,9280.9%
ARDELYX, INC.—$1.47M252,1980.9%
ASCENDIS PHARMA A/S—$1.46M6,8400.9%
Xeris Biopharma Holdings, Inc.—$1.34M170,5680.8%
RIGEL PHARMACEUTICALS, INC.—$1.28M30,0000.8%
SOLENO THERAPEUTICS, INC.—$1.25M26,8920.7%
Pacira BioSciences Inc—$1.24M48,0250.7%
Trevi Therapeutics, Inc.—$1.22M97,1840.7%
MAPLIGHT THERAPEUTICS INCMPLTCommon Stock$1.12M63,7910.7%
UNIQURE NV—$1.08M45,0000.6%
VAXCYTE, INC.—$1.06M22,9720.6%
ENANTA PHARMACEUTICALS INC—$1.03M65,1380.6%
PROTHENA CORP PUBLIC LTD CO—$1.02M106,5390.6%
Monte Rosa Therapeutics, Inc.—$976.6K62,2810.6%
Design Therapeutics, Inc.DSGNCommon Stock$941.0K100,3200.6%
Inovio Pharmaceuticals, Inc.—$928.6K533,6820.6%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$907.3K25,0000.5%
AYTU BIOPHARMA INC—$795.0K305,7880.5%
Pelthos Therapeutics Inc.PTHSCommon Stock$775.0K25,0000.5%
Liquidia CorpLQDACommon Stock$754.7K21,8810.4%
← PrevPage 1 of 2Next →